| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.011 | 1 |